RUSSO, GIANLUCA
 Distribuzione geografica
Continente #
NA - Nord America 464
EU - Europa 323
AS - Asia 106
AF - Africa 10
SA - Sud America 2
Totale 905
Nazione #
US - Stati Uniti d'America 462
IT - Italia 220
SG - Singapore 81
DE - Germania 38
ES - Italia 14
GB - Regno Unito 12
NL - Olanda 11
CN - Cina 8
IN - India 8
UA - Ucraina 8
CI - Costa d'Avorio 7
FI - Finlandia 6
IE - Irlanda 6
JP - Giappone 4
BE - Belgio 3
PK - Pakistan 3
BR - Brasile 2
FR - Francia 2
CA - Canada 1
EG - Egitto 1
GR - Grecia 1
MA - Marocco 1
MX - Messico 1
NP - Nepal 1
RO - Romania 1
RU - Federazione Russa 1
SC - Seychelles 1
VN - Vietnam 1
Totale 905
Città #
Chandler 113
Singapore 63
Naples 38
Milan 28
Ashburn 24
Rome 22
Lawrence 20
Santa Clara 16
Des Moines 15
Millbury 15
Amsterdam 11
Boston 10
Bologna 9
Valencia 9
Florence 8
Wilmington 8
Krefeld 7
Genoa 5
Cilavegna 4
Council Bluffs 4
Helsinki 4
Los Angeles 4
Sciacca 4
Bad Durrheim 3
Bari 3
Berlin 3
Casalnuovo di Napoli 3
Dublin 3
Fairfield 3
Fisciano 3
Grosseto 3
Houston 3
Karachi 3
Kronberg 3
London 3
Montalto di Castro 3
Napoli 3
Pamplona 3
Pune 3
Salt Lake City 3
Seattle 3
Venaria Reale 3
Agrate Brianza 2
Atlanta 2
Brindisi 2
Cagliari 2
Castellammare Di Stabia 2
Cava Manara 2
Dragoni 2
Ferrara 2
Foggia 2
Lappeenranta 2
Monza 2
New York 2
Norwalk 2
Pagani 2
Qualiano 2
Shanghai 2
São Paulo 2
Tokyo 2
Woodbridge 2
Alatri 1
Angri 1
Antwerp 1
Athens 1
Avellino 1
Bad Bellingen 1
Beijing 1
Boardman 1
Brussels 1
Campobasso 1
Chennai 1
Davis 1
Fiuggi 1
Formia 1
Frankfurt am Main 1
Galati 1
Gavirate 1
Genazzano 1
Greve in Chianti 1
Grezzana 1
Guangzhou 1
Hanoi 1
Kagoya 1
Kathmandu 1
Madrid 1
Monterrey 1
Munich 1
Pasadena 1
Perugia 1
Pescara 1
Pozzuoli 1
Rabat 1
Ravenna 1
Salerno 1
Santa Maria Capua Vetere 1
Toronto 1
Varese 1
Verona 1
Washington 1
Totale 575
Nome #
ESR1 mutations in HR+/HER2-metastatic breast cancer: Enhancing the accuracy of ctDNA testing 85
Predictive molecular pathology in metastatic thyroid cancer: the role of RET fusions 43
Liquid biopsy for BRAF mutations testing in non-small cell lung cancer: A retrospective study 42
Dealing with NSCLC EGFR mutation testing and treatment: A comprehensive review with an Italian real-world perspective 39
In-house homologous recombination deficiency testing in ovarian cancer: a multi-institutional Italian pilot study 37
Impact of Pre-Analytical Factors on MSI Test Accuracy in Mucinous Colorectal Adenocarcinoma: A Multi-Assay Concordance Study 37
Evaluation of the Molecular Landscape in PD-L1 Positive Metastatic NSCLC: Data from Campania, Italy 36
Liquid Biopsy Analysis in Clinical Practice: Focus on Lung Cancer 35
Next Generation Sequencing for liquid biopsy based testing in Non-Small Cell Lung Cancer in 2021 32
Brca1/2 ngs somatic testing in clinical practice: a short report 32
Methods for actionable gene fusion detection in lung cancer: now and in the future 30
Multi-gene custom panels for the characterisation of metastatic colorectal carcinoma in clinical practice: express the role of PIK3CA mutations 30
Critical aspects of MSI testing in endometrial cancer: a comparison study 28
Liquid Biopsy in Prostate Cancer Management{\textemdash}Current Challenges and Future Perspectives 28
Prostate health index and multiparametric mri: Partners in crime fighting overdiagnosis and overtreatment in prostate cancer 28
Fine-Needle Aspiration Is Suitable for Breast Cancer BRCA Molecular Assessment: A Case Report 26
Comparison of two next-generation sequencing-based approaches for liquid biopsy analysis in patients with non-small cell lung cancer: a multicentre study 25
BRAF: A Two-Faced Janus 25
Next generation sequencing in cytology 25
Next Generation Sequencing in Cytopathology: Focus on Non-Small Cell Lung Cancer 23
Evaluation of Micro Satellite Instability and Mismatch Repair Status in Different Solid Tumors: A Multicenter Analysis in a Real World Setting 22
The role of liquid biopsy in epithelial ovarian cancer: state of the art 21
Circulating tumor DNA in cancer: Predictive molecular pathology meets mathematics 20
MMR profile and microsatellite instability status in colorectal mucinous adenocarcinoma with synchronous metastasis: a new clue for the clinical practice 20
PIK3CA testing in hormone receptor-positive/HER2-negative metastatic breast cancer: real-world data from Italian molecular pathology laboratories 19
The evolving role of liquid biopsy in lung cancer 19
RNA-based next generation sequencing in non-small-cell lung cancer in a routine setting: an experience from an Italian referral center 19
Tumor mutational burden on cytological samples: A pilot study 18
A narrative review on the implementation of liquid biopsy as a diagnostic tool in thoracic tumors during the COVID-19 pandemic 18
Microsatellite instability evaluation of patients with solid tumour: routine practice insight from a large series of Italian referral centre 18
An Italian Multicenter Perspective Harmonization Trial for the Assessment of MET Exon 14 Skipping Mutations in Standard Reference Samples 17
Non-Small Cell Lung Cancer Testing on Reference Specimens: An Italian Multicenter Experience 16
Technical Validation of a Fully Integrated NGS Platform in the Real-World Practice of Italian Referral Institutions 15
Analytical Performance of Next-Generation Sequencing and RT-PCR on Formalin-Fixed Paraffin-Embedded Tumor Tissues for PIK3CA Testing in HR+/HER2− Breast Cancer 10
The Impact of potential ‘confounders’ on the diagnostic sensitivity of circulating free DNA in management of FIT+ patients: a pilot study 6
Genomic profiling of tissue and blood predicts survival outcomes in patients with resected pleural mesothelioma 5
Clinical utility of ctDNA by amplicon based next generation sequencing in first line non small cell lung cancer patients 3
Harnessing the potential of genomic characterization of mutational profiles to improve early diagnosis of lung cancer 3
Liquid biopsy: A promising tool for driving strategies and predicting failures in patients with classic Hodgkin lymphoma 1
Totale 956
Categoria #
all - tutte 4.928
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.928


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202156 0 0 0 0 0 11 5 12 7 9 6 6
2021/2022173 6 5 12 2 3 3 3 15 1 25 55 43
2022/2023300 26 14 17 12 46 41 1 34 45 20 41 3
2023/2024301 10 42 17 16 20 18 13 34 17 33 40 41
2024/2025126 54 58 6 8 0 0 0 0 0 0 0 0
Totale 956